Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Multicentre, randomised, open-label, phase IV-III study to evaluate the efficacy of cloxacillin plus fosfomycin versus cloxacillin alone in adult patients with methicillin-susceptible Staphylococcus aureus bacteraemia: study protocol for the SAFO trial.

Autor: Grillo S; Department of Infectious Diseases, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain.; Bellvitge Institute for Biomedical Research, IDIBELL, Barcelona, Spain., Cuervo G; Department of Infectious Diseases, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain guillermo.cuervo@bellvitgehospital.cat.; Bellvitge Institute for Biomedical Research, IDIBELL, Barcelona, Spain., Carratala J; Department of Infectious Diseases, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain.; University of Barcelona, Barcelona, Spain., San-Juan R; Department of Infectious Diseases, Hospital Universitario 12 de Octubre, Madrid, Spain.; Instituto de Investigación Hospital 12 de Octubre, Madrid, Spain., Aguado JM; Department of Infectious Diseases, Hospital Universitario 12 de Octubre, Madrid, Spain.; Complutense University of Madrid, Madrid, Spain., Morata L; Department of Infectious Diseases, Hospital Clinic de Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer, IDIBAPS, Barcelona, Spain., Gomez-Zorrilla S; Department of Infectious Diseases, Consorci Parc de Salut MAR de Barcelona, Barcelona, Spain.; Institut de Recerca Hospital del Mar, IMIM, Barcelona, Spain., López-Contreras J; Department of Infectious diseases, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.; Institut d'Investigació Biomèdica Sant Pau IIB Sant Pau, Barcelona, Spain., Gasch O; Infectious Diseases Department, Consorcio Corporacion Sanitaria Parc Tauli, Sabadell, Spain.; Institut d'Investigació i Innovació Parc Taulí, I3PT, Sabadell, Spain., Gomila-Grange A; Institut d'Investigació i Innovació Parc Taulí, I3PT, Sabadell, Spain.; Consorcio Corporación Sanitaria Parc Taulí, Sabadell, Spain., Iftimie S; Department of Infection and Immunity, Hospital Universitari Sant Joan de Reus, Reus, Spain., Garcia-Pardo G; Departament of Preventive Medicine, Hospital Universitari de Tarragona Joan XXIII, Tarragona, Spain., Calbo E; Infectious Diseases Unit, Hospital Universitari MutuaTerrassa, Terrassa, Spain.; Fundació per la Docència i Recerca MútuaTerrassa, Terrassa, Spain., Boix-Palop L; Infectious Diseases Unit, Hospital Universitari MutuaTerrassa, Terrassa, Spain.; Fundació per la Docència i Recerca MútuaTerrassa, Terrassa, Spain., Oriol I; Department of Internal Medicine, Hospital de Sant Joan Despi Moises Broggi, Sant Joan Despi, Spain., Jover-Sáenz A; Territorial Unit of Nosocomial Infection, Hospital Universitari Arnau de Vilanova, Lleida, Spain.; Institut de Recerca Biomèdica de Lleida, IRBLLEIDA, Lleida, Spain., López-Cortés LE; Department of Infectious diseases, Hospital Universitario Virgen Macarena, Seville, Spain.; Instituto de Biomedicina de Sevilla, Sevilla, Spain., Euba G; Department of Infectious Diseases, Hospital Universitario Cruces, Barakaldo, Spain.; Biocruces Bizkaia Health Research Institute, Barakaldo, Spain., Aguirregabiria M; Biocruces Bizkaia Health Research Institute, Barakaldo, Spain.; Microbiology Department, Hospital Universitario Cruces, Barakaldo, Spain., Garcia-Pais MJ; Internal Medicine, Hospital Universitario Lucus Augusti, Lugo, Spain.; Instituto de Investigación Sanitaria de Santiago de Compostela, Santiago de Compostela, Spain., Gioia F; Department of Infectious diseases, Hospital Universitario Ramon y Cajal, Madrid, Spain.; Instituto Ramón y Cajal de Investigación Sanitaria, Madrid, Spain., Paño JR; Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain.; Instituto de Investigación Sanitaria Aragón, Zaragoza, Spain., Pedro-Botet ML; Hospital Universitari Germans Trias i Pujol, Badalona, Spain.; Fundació Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol, Badalona, Spain., Benítez RM; Hospital Universitari Germans Trias i Pujol, Badalona, Spain.; Fundació Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol, Badalona, Spain., Pérez-Rodríguez MT; Department of Internal Medicine and Infectious Diseases, Hospital Álvaro Cunqueiro, Vigo, Spain., Meije Y; Hospital de Barcelona, Barcelona, Spain.; Societat Cooperativa d'Instal·lacions Assistencials Sanitàries, Barcelona, Spain., Loeches-Yagüe MB; Department of Infectious Diseases, Hospital Universitario La Paz, Madrid, Spain., Horna G; Bellvitge Institute for Biomedical Research, IDIBELL, Barcelona, Spain., Berbel D; Bellvitge Institute for Biomedical Research, IDIBELL, Barcelona, Spain.; Department of Microbiology and Parassitology, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain., Domínguez MÁ; Bellvitge Institute for Biomedical Research, IDIBELL, Barcelona, Spain.; Department of Microbiology and Parassitology, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain., Padullés A; Bellvitge Institute for Biomedical Research, IDIBELL, Barcelona, Spain.; Pharmacy Department, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain., Cobo S; Bellvitge Institute for Biomedical Research, IDIBELL, Barcelona, Spain.; Pharmacy Department, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain., Hereu P; Bellvitge Institute for Biomedical Research, IDIBELL, Barcelona, Spain.; Department of Clinical Pharmacology, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain., Videla S; Bellvitge Institute for Biomedical Research, IDIBELL, Barcelona, Spain.; Department of Clinical Pharmacology, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain., Tebe C; University of Barcelona, Barcelona, Spain.; Biostatistics Unit, Institut d'Investigacio Biomedica de Bellvitge, L'Hospitalet de Llobregat, Spain., Pallarés N; University of Barcelona, Barcelona, Spain.; Biostatistics Unit, Institut d'Investigacio Biomedica de Bellvitge, L'Hospitalet de Llobregat, Spain., Miro JM; Department of Infectious Diseases, Hospital Clinic de Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer, IDIBAPS, Barcelona, Spain., Pujol M; Department of Infectious Diseases, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain.; Bellvitge Institute for Biomedical Research, IDIBELL, Barcelona, Spain.

Publikováno v: BMJ open [BMJ Open] 2021 Aug 05; Vol. 11 (8), pp. e051208. Date of Electronic Publication: 2021 Aug 05.

Type 3 secretion system as an anti-Pseudomonal target.

Autor: Horna G; Universidad Catolica Los Angeles de Chimbote, Instituto de Investigación, Chimbote, Peru., Ruiz J; Laboratorio de Microbiología Molecular y Genómica Bacteriana, Universidad Científica del Sur, Lima, Peru. Electronic address: jruizb@cientifica.edu.pe.

Publikováno v: Microbial pathogenesis [Microb Pathog] 2021 Jun; Vol. 155, pp. 104907. Date of Electronic Publication: 2021 Apr 28.

Current Progress in the Development of mRNA Vaccines Against Bacterial Infections.

Autor: Khlebnikova, Alina¹ (AUTHOR), Kirshina, Anna¹ (AUTHOR) kirshina.as@talantiuspeh.ru, Zakharova, Natalia¹ (AUTHOR) alina.s.x@yandex.ru, Ivanov, Roman¹ (AUTHOR), Reshetnikov, Vasiliy¹ (AUTHOR) kirshina.as@talantiuspeh.ru

Publikováno v: International Journal of Molecular Sciences. Dec2024, Vol. 25 Issue 23, p13139. 35p.

Antimicrobial drug resistance in Peru [letter]

Autor: García, C., Horna, G., Linares, E., Ramírez, R., Tapia, E., Velásquez, J., Medina, V., Guevara, J., Urbina, M., Zevallos, S., Espinoza, N., Samalvides, F., Jacobs, J.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______1507::e50ff316266e8c2ddadc76dac7481dfd
http://193.190.39.98/bitstream/10390/691/1/2012eidi0520.pdf